The IZAR Study for Psoriatic Arthritis
The IZAR Study for Psoriatic Arthritis
Psoriatic arthritis (PsA) is a painful condition that can affect both the joints and skin. PsA is not caused by overuse of joints or aging – rather, it is the result of an overactive immune system and can affect people at any age.
Common symptoms of psoriatic arthritis include pain or swelling in one or more joints, swollen fingers and/or toes, and patches of red, scaly skin (psoriasis).
If you struggle with psoriatic arthritis, you may qualify for the IZAR Clinical Study, now being offered at select medical centers. The IZAR Study is evaluating an injectable investigational medication aimed at alleviating PsA symptoms. If you qualify and choose to join the IZAR Study, you will receive study-related care and monitoring of your PsA condition at no cost. You may also be compensated for your time and travel to attend any required study visits at your local study doctor’s office.
MyStudies Partner:
Get Notified About Upcoming Trials
Sign up to receive information about clinical trials, studies, and surveys in your area – right to your inbox.
The featured MyStudies are paid advertisements from our partners. Information contained in these listings is for general informational purposes only and does not constitute an endorsement, recommendation, or certification of any kind by NPF. Persons participating in trials, studies, or surveys assume responsibility for their participation and are advised to discuss the information shown with their health care provider.